Optimizing the Outcomes of Percutaneous Coronary Intervention in Patients with Chronic Kidney Disease
Alessandro Caracciolo, Renato Francesco Maria Scalise, Fabrizio Ceresa, Gianluca Bagnato, Antonio Giovanni Versace, Roberto Licordari, Silvia Perfetti, Francesca Lofrumento, Natasha Irrera, Domenico Santoro, Francesco Patanè, Gianluca Di Bella, Francesco Costa, Antonio Micari
Abstract
Percutaneous coronary intervention (PCI) is one of the most common procedures performed in medicine. However, its net benefit among patients with chronic kidney disease (CKD) is less well established than in the general population. The prevalence of patients suffering from both CAD and CKD is high, and is likely to increase in the coming years. Planning the adequate management of this group of patients is crucial to improve their outcome after PCI. This starts with proper preparation before the procedure, the use of all available means to reduce contrast during the procedure, and the implementation of modern strategies such as radial access and drug-eluting stents. At the end of the procedure, personalized antithrombotic therapy for the patient's specific characteristics is advisable to account for the elevated ischemic and bleeding risk of these patients.